Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03263702 · ClinicalTrials.gov registry record · NA
RADAR Clinical Trial
A NA study of Persistent Atrial Fibrillation, sponsored by Vivek Reddy.
- Completed
- Registry status
- NA
- Development phase
- 65
- Enrollment target
- 4
- Study locations
NCT03263702: Completed NA study of Persistent Atrial Fibrillation, sponsored by Vivek Reddy.
NCT03263702 is a NA study of Persistent Atrial Fibrillation that has completed, run by Vivek Reddy. The registered enrollment target is 65 participants, below the 1,256-participant average among 15 other Persistent Atrial Fibrillation trials with a reported enrollment target (95% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03263702, a NA study of Persistent Atrial Fibrillation, has completed, sponsored by Vivek Reddy.
- COMPLETED
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
- 4
- Study locations
Study Summary
This prospective, multicenter, observational study will examine the ability of real time electrogram processing mapping to identify driver domains to target for ablation in persistent AF patients.
Primary Outcome
Acute Procedural Outcomes as defined by termination of Atrial Fibrillation into normal sinus rhythm (NSR) or atrial tachycardia (AT)
Conditions Studied
Interventions
- DEVICE Computational Mapping Algorithm
Study Locations (4)
Colorado
- University of Colorado Medical Center - Denver
- South Denver Cardiology - Denver
Massachusetts
- Massachusetts General Hospital - Boston
New York
- Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2017-06-26 |
| Est. Completion | 2019-06-07 |
| Phase | NA |
What the finished NCT03263702 record still lists
NCT03263702 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 65 participants, a relatively small participant target, below the 1,256-participant average among 15 other Persistent Atrial Fibrillation trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Persistent Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Computational Mapping Algorithm is the first listed.
NCT03263702 reports a single indexed study location in Colorado, Massachusetts, New York.
Frequently Asked Questions
What is clinical trial NCT03263702 about?
NCT03263702 is a clinical study titled "RADAR Clinical Trial". This prospective, multicenter, observational study will examine the ability of real time electrogram processing mapping to identify driver domains to target for ablation in persistent AF patients.
What is the current status of trial NCT03263702?
This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2017-06-26. Estimated completion is 2019-06-07.
What conditions does trial NCT03263702 study?
This clinical trial studies the following conditions: Persistent Atrial Fibrillation.
What interventions are being tested in trial NCT03263702?
The interventions under investigation include: Computational Mapping Algorithm (DEVICE).
Who is sponsoring clinical trial NCT03263702?
This trial is sponsored by Vivek Reddy, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03263702 being conducted?
This trial has 4 study locations across Colorado, Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Persistent Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03263702's enrollment target sits among peer trials
65 15th of 15 higher than 1 of 15 other Persistent Atrial Fibrillation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Persistent Atrial Fibrillation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Endocardial Mapping With the CoreMap EP Mapping System
RECRUITING · NA
-
ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients
RECRUITING · NA
-
ARIADNE Clinical Trial
RECRUITING · NA
-
Medtronic Terminate AF Study
RECRUITING · NA
-
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
RECRUITING · NA
-
Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03366116 · 65 participants · Phase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- NCT03603730 · 65 participants · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
- NCT03796559 · 65 participants · NA
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- NCT03993106 · 65 participants · Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI